RU92016471A - Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате - Google Patents

Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате

Info

Publication number
RU92016471A
RU92016471A RU92016471/14A RU92016471A RU92016471A RU 92016471 A RU92016471 A RU 92016471A RU 92016471/14 A RU92016471/14 A RU 92016471/14A RU 92016471 A RU92016471 A RU 92016471A RU 92016471 A RU92016471 A RU 92016471A
Authority
RU
Russia
Prior art keywords
preparation
solid non
porous microsphere
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
RU92016471/14A
Other languages
English (en)
Other versions
RU2104692C1 (ru
Inventor
Гарса Флорес Жозуе
П.Лайсека Сото Лаура
Гиллен Пишардо Жозе
Ангелес Урибе Жуан
Original Assignee
Апликасионс Фармасеутикас С.А. Де С.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9007416A external-priority patent/FR2663223B1/fr
Application filed by Апликасионс Фармасеутикас С.А. Де С.В. filed Critical Апликасионс Фармасеутикас С.А. Де С.В.
Publication of RU92016471A publication Critical patent/RU92016471A/ru
Application granted granted Critical
Publication of RU2104692C1 publication Critical patent/RU2104692C1/ru

Links

Claims (1)

  1. Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате относятся к микросферам на основе активного вещества, способу их получения и применению в фармацевтических композициях, предназначенных для инъекций.
RU92016471A 1990-06-14 1991-06-12 Твердая непористая микросфера, способ ее получения и суспензия для парентеральной инъекции на основе данных микросфер RU2104692C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9007416 1990-06-14
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.
PCT/EP1991/001096 WO1991019484A1 (fr) 1990-06-14 1991-06-12 Composition pharmaceutique injectable

Publications (2)

Publication Number Publication Date
RU92016471A true RU92016471A (ru) 1995-03-10
RU2104692C1 RU2104692C1 (ru) 1998-02-20

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92016471A RU2104692C1 (ru) 1990-06-14 1991-06-12 Твердая непористая микросфера, способ ее получения и суспензия для парентеральной инъекции на основе данных микросфер

Country Status (30)

Country Link
US (3) US5360616A (ru)
EP (1) EP0533739B1 (ru)
JP (1) JP2675675B2 (ru)
KR (1) KR0157439B1 (ru)
CN (1) CN1057442C (ru)
AT (1) ATE109658T1 (ru)
AU (1) AU661275B2 (ru)
BG (1) BG61179B1 (ru)
BR (1) BR9106545A (ru)
CA (1) CA2085344C (ru)
CZ (1) CZ286793B6 (ru)
DE (1) DE69103419T2 (ru)
DK (1) DK0533739T3 (ru)
ES (1) ES2059142T3 (ru)
FI (1) FI107698B (ru)
FR (1) FR2663223B1 (ru)
HU (1) HUT68709A (ru)
IE (1) IE62679B1 (ru)
IL (1) IL98459A (ru)
NO (1) NO302998B1 (ru)
NZ (1) NZ238542A (ru)
PL (1) PL167234B1 (ru)
PT (1) PT97975B (ru)
RU (1) RU2104692C1 (ru)
SK (1) SK280564B6 (ru)
TN (1) TNSN91048A1 (ru)
UA (1) UA27043C2 (ru)
UY (1) UY23240A1 (ru)
WO (1) WO1991019484A1 (ru)
ZA (1) ZA914550B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
AU753278B2 (en) * 1998-02-25 2002-10-10 Abbott Laboratories Butorphanol sustained release formulations
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
JP2003526629A (ja) * 1999-08-20 2003-09-09 ノートン ヘルスケアー リミテッド 経肺または経鼻投与のための粉末の製造法
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
SI1820494T1 (sl) * 2003-06-13 2010-08-31 Skendi Finance Ltd Mikrodelci, ki sestojijo iz estradiola in holesterola
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
AU2004267956B2 (en) 2003-09-03 2010-09-16 Miscon Trading S.A. Methods for the treatment of endometriosis
US7205281B2 (en) 2003-10-03 2007-04-17 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
ES2315721T5 (es) * 2003-10-23 2012-08-24 Otsuka Pharmaceutical Co., Ltd. Formulación de aripiprazol inyectable estéril de liberación controlada y procedimiento
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP2236546B1 (en) 2006-10-31 2011-12-28 Surmodics Pharmaceuticals, Inc. Speronized polymer particles
LT2170279T (lt) 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
CN102056611A (zh) * 2008-04-14 2011-05-11 Posi维森纳里解决方案有限责任公司 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物
US8905913B2 (en) 2009-04-23 2014-12-09 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
RU2015125549A (ru) 2012-11-28 2017-01-11 ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК Способ для синхронизации времени осеменения молодых свиней
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
JP2019506443A (ja) * 2016-02-24 2019-03-07 イースタン バージニア メディカル スクール 改良された持効性注射用デポ型ブタン酸レボノルゲストレル懸濁製剤
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (ru) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (ru) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
ATE109941T1 (de) * 1987-04-06 1994-09-15 Endocon Inc Durch schnellschmelzen hergestellte medizinische implantate.
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres

Similar Documents

Publication Publication Date Title
RU92016471A (ru) Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате
DE10199049I1 (de) Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
ATA333087A (de) Pharmazeutisches präparat für die intravenöse wirkstoffapplikation mit hydrosolen im nanometerbereich
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69202060T2 (de) OPTISCH AKTIVES 5H-PYRROLO[3,4-b]PYRAZINDERIVAT, SEINE HERSTELLUNG UND PHARMAZEUTISCHE ZUBEREITUNGEN DIE ES ENTHALTEN.
EP0983995A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
ATE179602T1 (de) Stabilisierte, feste pharmazeutische zubereitung, die dextromethorphan phenylpropanolamine und coffein enthält
FR2601259B1 (fr) Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
CA2011452A1 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7–,17–)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
IT8722264A0 (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
DE69012031T2 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
ATE29878T1 (de) Pharmazeutisch wirksame verbindungen und deren herstellung.
NO871190D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
NO176180C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-karbonyl-substituerte N,N-di(trimetoksybenzoyl) piperanziner
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
DE3881812T2 (de) Physiologisch aktive Substanzen, Probestin und Prostatin und deren Herstellung.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
IT1201431B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene